Vimarsana
Biggest News Aggregation in the World

Impaired Mobility News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Impaired Mobility. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Impaired Mobility Today - Breaking & Trending Today

MedPAC May Tell Medicare to Slim Down Its Alternative Payment Offerings - Vimarsana News

MedPAC May Tell Medicare to Slim Down Its Alternative Payment Offerings

email article WASHINGTON -- The Centers for Medicare & Medicaid Services (CMS) should reduce its portfolio of alternative payment models, according to a draft recommendation released by the Medicare Payment Advisory Commission (MedPAC). "I think there's merit in streamlining the models," commission member Brian DeBusk, PhD, CEO of DeRoyal Industries in Powell, Tennessee, said Thursday at MedPAC's March meeting. Medicare "might welcome the relief; I'm sure they get pressed from a lot of different sides to pursue a lot of different programs." DeBusk was responding to a draft recommendat...

APA Apologizes for Racism; Pot Abuse, Bipolar Disorder & Mortality - Vimarsana News

APA Apologizes for Racism; Pot Abuse, Bipolar Disorder & Mortality

email article The American Psychiatric Association released an apology to Black, indigenous, and other people of color for the role it played in structural racism. In young people with mood disorders -- particularly bipolar disorder -- cannabis abuse was tied to significantly higher probability of all-cause mortality. ( JAMA Pediatrics) An investigational extended-release amphetamine tablet effectively achieved an improvement in average Permanent Product Measure of Performance-Total (PERMP-T) score maintained to 13 hours after the first dose, Tris Pharma announced. Peer support at s...

EARLY Results Not All Bad; Fauci Admits GBS Vax Advice Error - Vimarsana News

EARLY Results Not All Bad; Fauci Admits GBS Vax Advice Error

(Movement Disorders) People who had one traumatic brain injury (TBI) had twice the risk of epilepsy as those who had none; people who had two TBIs had four times the risk. (Brain) The HELIOS-A phase III study of vutrisiran, an investigational RNAi treatment, met its primary and secondary endpoints at 9 months in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy, Alnylam announced. National Institute of Allergy and Infectious Diseases Director Anthony Fauci, MD, said he "stands corrected" and that he misspoke in a televised interview when he said people who've ha...

Who's Missing Out With Virtual Visits? - Vimarsana News

Who's Missing Out With Virtual Visits?

Large health system reports unequal access to telemedicine